Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 19351-19400 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT02344680
Liver Fibrosis in Zambian HIV-HBV Co-infected Patients
N/A
Active, not recruiting
303 participants
Started: Oct 31, 2015 · Completed: Apr 30, 2026
7 conditions
3 sponsors
1 location
NCT02577926
The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential Thrombocythemia
PHASE2
Active, not recruiting
207 participants
Started: Oct 31, 2015 · Completed: Dec 31, 2028
2 conditions
2 sponsors
23 locations
NCT02804815
Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours
PHASE3
Active, not recruiting
11,000 participants
Started: Oct 31, 2015 · Completed: Oct 31, 2026
5 conditions
1 sponsor
82 locations
NCT02542657
Ixazomib with Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients with Multiple Myeloma
PHASE1/PHASE2
Active, not recruiting
30 participants
Started: Oct 31, 2015 · Completed: Dec 31, 2025
1 condition
3 sponsors
3 locations
NCT02588989
Fibrosis, Valvular and Ventricular Function in Patients With TGA
N/A
Active, not recruiting
37 participants
Started: Oct 31, 2015 · Completed: Jun 30, 2027
1 condition
1 sponsor
1 location
NCT02578446
Uncemented Tritanium Compared With Cemented Metal-backed Tibia Components in Total Knee Replacement
NA
Active, not recruiting
72 participants
Started: Oct 31, 2015 · Completed: Mar 31, 2027
3 conditions
3 sponsors
2 locations
NCT02486718
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]
PHASE3
Active, not recruiting
1,280 participants
Started: Oct 31, 2015 · Completed: Aug 30, 2035
1 condition
1 sponsor
153 locations
NCT02632422
AIH-induced Walking Recovery After Subacute SCI
NA
Active, not recruiting
125 participants
Started: Oct 31, 2015 · Completed: Dec 30, 2024
1 condition
2 sponsors
2 locations
NCT02446093
Neoadjuvant CAN-2409 in Combination With Chemoradiation or SBRT for Borderline Resectable Pancreatic Adenocarcinoma
PHASE2
Active, not recruiting
54 participants
Started: Oct 31, 2015 · Completed: Jul 31, 2026
1 condition
2 sponsors
3 locations
NCT02339779
Breast Reconstruction With External Pre-expansion and Autologous Fat Transfer Versus Standard Therapy
NA
Active, not recruiting
196 participants
Started: Oct 31, 2015 · Completed: Oct 31, 2026
1 condition
2 sponsors
7 locations
NCT02521844
A Study to Evaluate the Safety and Tolerability of ETC-1922159 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumours
PHASE1
Active, not recruiting
89 participants
Started: Oct 31, 2015 · Completed: Oct 31, 2024
1 condition
2 sponsors
11 locations
NCT02557321
PV-10 in Combination With Pembrolizumab for Treatment of Metastatic Melanoma
PHASE1/PHASE2
Active, not recruiting
50 participants
Started: Oct 31, 2015 · Completed: Apr 30, 2025
1 condition
1 sponsor
5 locations
NCT02570542
Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)
PHASE2
Active, not recruiting
59 participants
Started: Oct 31, 2015 · Completed: Oct 31, 2025
3 conditions
8 sponsors
14 locations
NCT02562235
Riociguat in Children With Pulmonary Arterial Hypertension (PAH)
PHASE3
Active, not recruiting
24 participants
Started: Oct 29, 2015 · Completed: Aug 3, 2027
1 condition
2 sponsors
16 locations
NCT02436707
Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma
PHASE2
Active, not recruiting
129 participants
Started: Oct 27, 2015 · Completed: Dec 31, 2026
1 condition
4 sponsors
12 locations
NCT02482376
Preoperative Single-Fraction Radiotherapy in Early Stage Breast Cancer
PHASE2
Active, not recruiting
68 participants
Started: Oct 21, 2015 · Completed: Mar 10, 2032
1 condition
2 sponsors
1 location
NCT02447549
Study of Tumour Focused Radiotherapy for Bladder Cancer
PHASE2
Active, not recruiting
345 participants
Started: Oct 21, 2015 · Completed: Mar 31, 2029
1 condition
2 sponsors
49 locations
NCT02511106
AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy.
PHASE3
Active, not recruiting
682 participants
Started: Oct 21, 2015 · Completed: Jan 31, 2029
1 condition
1 sponsor
238 locations
NCT02445391
Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy
PHASE3
Active, not recruiting
415 participants
Started: Oct 20, 2015 · Completed: Mar 29, 2031
12 conditions
2 sponsors
1024 locations
NCT02553447
Cholecalciferol in Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia With Vitamin D Deficiency
NA
Active, not recruiting
197 participants
Started: Oct 19, 2015 · Completed: Mar 31, 2025
4 conditions
2 sponsors
1 location
NCT03191916
Transcranial Direct Current Stimulation for Cognitive Improvement in Parkinson's Patients
NA
Active, not recruiting
40 participants
Started: Oct 19, 2015 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT02519348
A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma
PHASE2
Active, not recruiting
433 participants
Started: Oct 19, 2015 · Completed: Apr 1, 2026
1 condition
1 sponsor
44 locations
NCT02552823
Effects of Peas on Blood Glucose Control
NA
Active, not recruiting
64 participants
Started: Oct 16, 2015 · Completed: Jan 31, 2025
1 condition
2 sponsors
1 location
NCT02537418
Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Given With or Without Standard Chemotherapy Regimens
PHASE1
Active, not recruiting
153 participants
Started: Oct 16, 2015 · Completed: Jan 30, 2026
1 condition
2 sponsors
7 locations
NCT02612454
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)
PHASE3
Active, not recruiting
880 participants
Started: Oct 15, 2015 · Completed: Oct 7, 2026
1 condition
2 sponsors
84 locations
NCT06934460
Direct Versus Indirect Endocrowns on Endodontically Treated Molars
NA
Active, not recruiting
102 participants
Started: Oct 12, 2015 · Completed: Nov 30, 2028
4 conditions
1 sponsor
0 locations
NCT02298348
Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma
PHASE1
Active, not recruiting
18 participants
Started: Oct 8, 2015 · Completed: Dec 31, 2025
1 condition
13 sponsors
12 locations
NCT03597204
Effectiveness of Fecal Immunnochemical Test and Colonoscopy Screening in Hong Kong
NA
Active, not recruiting
15,000 participants
Started: Oct 7, 2015 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT02389309
Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors
PHASE1
Active, not recruiting
14 participants
Started: Oct 5, 2015 · Completed: Oct 31, 2027
4 conditions
2 sponsors
1 location
NCT02562118
Neoadjuvant Lenvatinib Combined With Letrozole in Hormone Receptor Positive Breast Cancer
PHASE1/PHASE2
Active, not recruiting
40 participants
Started: Oct 2, 2015 · Completed: Jun 30, 2027
1 condition
2 sponsors
1 location
NCT03336658
Intratumoral Budding (ITB) in Preoperative Biopsies of Colon and Rectal Cancer
N/A
Active, not recruiting
150 participants
Started: Oct 1, 2015 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT02684708
Second International Inter-Group Study for Classical Hodgkin Lymphoma in Children and Adolescents
PHASE3
Active, not recruiting
2,200 participants
Started: Oct 1, 2015 · Completed: Sep 30, 2026
1 condition
3 sponsors
19 locations
NCT05216029
Oncology Dashboard for the Improvement of Operational Efficiency and Patients Outcomes in Patients With Sarcoma
NA
Active, not recruiting
92 participants
Started: Oct 1, 2015 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT02573766
Neuromodulation as a Treatment for Chemotherapy-Induced Peripheral Neuropathy
NA
Active, not recruiting
91 participants
Started: Oct 1, 2015 · Completed: Oct 1, 2026
1 condition
3 sponsors
1 location
NCT02875314
HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors
PHASE4
Active, not recruiting
250 participants
Started: Sep 30, 2015 · Completed: Dec 31, 2030
2 conditions
2 sponsors
62 locations
NCT02576431
A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
PHASE2
Active, not recruiting
215 participants
Started: Sep 30, 2015 · Completed: Oct 31, 2025
1 condition
1 sponsor
98 locations
NCT02514512
Lung Cancer Radiotherapy Using Realtime Dynamic Multileaf Collimator (MLC) Adaptation And Radiofrequency Tracking
NA
Active, not recruiting
20 participants
Started: Sep 30, 2015 · Completed: Dec 31, 2026
2 conditions
3 sponsors
1 location
NCT02767505
Bypass Equipoise Sleeve Trial (BEST)
NA
Active, not recruiting
1,752 participants
Started: Sep 30, 2015 · Completed: Dec 31, 2031
1 condition
22 sponsors
21 locations
NCT02344472
Detect V / CHEVENDO (Chemo vs. Endo)
PHASE3
Active, not recruiting
271 participants
Started: Sep 30, 2015 · Completed: Jan 31, 2025
1 condition
5 sponsors
1 location
NCT06637722
Self-management in Patients With Adrenal Insufficiency.
N/A
Active, not recruiting
450 participants
Started: Sep 30, 2015 · Completed: Mar 31, 2025
1 condition
1 sponsor
0 locations
NCT02613702
Efficacy of a Modified Technique of Free Gingival Graft in Volumetric Changes of the Graft: Randomized Clinical Trial
NA
Active, not recruiting
40 participants
Started: Sep 30, 2015 · Completed: Jul 31, 2025
1 condition
2 sponsors
1 location
NCT02965638
Trial of Maternal Oxygen for Fetal Left Heart Hypoplasia
NA
Active, not recruiting
12 participants
Started: Sep 30, 2015 · Completed: Jul 31, 2027
1 condition
1 sponsor
1 location
NCT02308072
Phase I Study of Olaparib Combined With Cisplatin-based Chemoradiotherapy to Treat Locally Advanced Head and Neck Cancer
PHASE1
Active, not recruiting
70 participants
Started: Sep 30, 2015 · Completed: Feb 28, 2025
1 condition
3 sponsors
3 locations
NCT02567136
Imaging Biomarkers in ALS
N/A
Active, not recruiting
30 participants
Started: Sep 30, 2015 · Completed: Sep 30, 2025
2 conditions
1 sponsor
1 location
NCT02466737
Comparison of Axillary Sentinel Lymph Node Biopsy Versus no Axillary Surgery
NA
Active, not recruiting
5,505 participants
Started: Sep 30, 2015 · Completed: Jun 30, 2025
1 condition
3 sponsors
150 locations
NCT02483312
A Study of (Interleukin-12) IL-12 in Patients With Acute Myelogenous Leukemia (AML)
PHASE1
Active, not recruiting
9 participants
Started: Sep 30, 2015 · Completed: Aug 31, 2025
1 condition
2 sponsors
1 location
NCT02538991
TVT Versus Bulkamid®-Injections in Treatment of Stress Urinary Incontinence
NA
Active, not recruiting
224 participants
Started: Sep 30, 2015 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT02510625
The Arthroscopic Treatment of Recurrent Anterior Shoulder Instability
NA
Active, not recruiting
200 participants
Started: Sep 30, 2015 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT02440672
JOURNEY™ II CR Total Knee System
N/A
Active, not recruiting
170 participants
Started: Sep 30, 2015 · Completed: Jun 30, 2028
1 condition
1 sponsor
9 locations
NCT02562131
PET-MR-PSA Prostate Cancer Recidive Study
N/A
Active, not recruiting
80 participants
Started: Sep 30, 2015 · Completed: Dec 31, 2027
1 condition
2 sponsors
1 location
Previous
1
More pages
385
386
387
388
389
390
391
More pages
431
Next